Global IVD Assay Development Market Forecast
Meticulous Research®—a leading market research company, published a research report titled, ‘IVD Assay Development Market Size, Share, Forecast, & Trends Analysis by Offering (Assay Development, Packaging Development) Technology (Immunoassay, Molecular Diagnostics, Biochemistry) Application (Oncology, Diabetes) – Global Forecast to 2031.’ According to this latest publication from Meticulous Research®, the IVD assay development market is projected to reach $8.39 billion by 2031, at a CAGR of 7.9% from 2024 to 2031.
The growth of the IVD assay
development market is driven by the rising prevalence of chronic diseases &
the increasing geriatric population, the high burden of infectious diseases,
the growing focus on the development of POC IVD assays, and rising healthcare
expenditures. However, the evolving regulatory landscape restrains this
market’s growth.
Moreover, the emerging economies and
the use of advanced technologies in IVD assay development are expected to
generate growth opportunities for market stakeholders. Maintaining product
quality & protecting proprietary information pose challenges to the growth
of the market.
Key Players
The key players profiled in the IVD
assay development market report are Thermo Fisher Scientific Inc. (U.S.),
Avioq, Inc. (U.S.), Creative Biolabs, Inc (U.S.), Maxim Biomedical, Inc.
(U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), PeploBio Ltd
(U.K.), ICON plc (Ireland), NeoDx Biotech Labs Pvt. Ltd. (India), Eclevar
Medtech (France), Savyon Diagnostics (Israel), Promega Corporation (U.S.), and
Future Diagnostics Solutions B.V. (Netherlands).
The IVD assay development market is
segmented by offering, technology, and application. The report also evaluates
industry competitors and analyzes the IVD assay development market at the
regional and country levels.
Among the offerings studied in this
report, in 2024, the IVD
assay development services segment is anticipated to dominate the IVD assay
development market, with a share of 45.1%. Assay development
services have various phases, including the selection of key raw materials, the
screening of raw materials, preliminary feasibility studies, the optimization
of assay parameters, the verification of assay designs, and clinical sample testing.
The increased usage of IVD tests in drug discovery is driving the demand for
IVD assay development services. IVD assays are essential for assessing
pharmaceutical candidates, detecting biomarkers, making treatment decisions,
and identifying patients for specific therapy. With pharmaceutical companies'
transition to customized medicine and precision therapies, the demand for
high-quality IVD assays is fast increasing. These are factors contributing to
the segment’s dominant position in the IVD assay development market.
Among the technologies studied in
this report, in 2024, the
immunoassay/immunochemistry segment is anticipated to dominate the IVD assay
development market, with a share of 42.3%.
Immunoassay/immunochemistry is a bioanalytical method in which the quantitation
of the analyte depends on the reaction of an antigen and an antibody.
Immunoassay technologies utilize antigen-antibody reactions for the detection
of causative agents. In addition, higher preference for immunodiagnostics
compared to other technologies owing to its inherent specificity and high
throughput and the emergence of advanced diagnostic immunoassay formats.
Further, the growing use of immunoassays in Point-of-care (PoC) infectious
disease testing, the increasing need to develop novel assays, and the rising
aging population are factors contributing to the segment’s dominant position in
the IVD assay development market.
Among the applications studied in
this report, in 2024, the
infectious diseases segment is anticipated to dominate the IVD assay
development market. Infectious diseases are transmissible illnesses that can
spread rapidly, making accurate diagnosis essential to prevent further
transmission. IVD assays are widely recognized as effective tools for
diagnosing infectious diseases. The segment’s dominant position in the IVD
assay development market can be attributed to government initiatives to promote
awareness and testing, advancements in diagnostic techniques, recent outbreaks
of infectious diseases globally, and the rising prevalence of such diseases.
According to the WHO, there were 39.9 million cases of HIV worldwide at the end
of 2023, compared to 25.6 million cases in 2021.
Among the regions studied in this
report, in 2024, North America
is anticipated to dominate the IVD assay development market, with a share
of 37.8%. The large share of this segment is attributed to factors
such as favorable government investments and funding for disease investigation
& prevention, high prevalence of various infectious diseases and chronic
diseases, well-developed healthcare sector, awareness regarding early disease
diagnosis, early adoption of advanced innovative diagnostic products which are
significant factors driving the growth of the IVD assay development market in
the region.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6037
Key questions answered in the
report-
·
Which are
the high-growth market segments in the IVD assay development market in terms of
offering, technology, application, and geography?
·
What was
the historical market for IVD assay development across the globe?
·
What are
the market forecasts and estimates for the period 2024–2031?
·
What are
the major drivers, restraints, opportunities, and challenges in the IVD assay
development market?
·
Who are
the major players in the IVD assay development market?
·
What is
the competitive landscape like?
·
What are
the recent developments in the IVD assay development market?
·
What are
the different strategies adopted by the major players in the IVD assay
development market?
·
What are
the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment